Loudoun Medical Group

Loudoun Medical Group Accountable Care Organization

ACO Name and Location

Loudoun Medical Group ACO LLC
Previous Names: N/A
224D Cornwall St NW
Ste 403
Leesburg, VA 20176

ACO Primary Contact

Mary Beth Tamasy, CEO
(703) 737-6006
mtamasy@lmgdoctors.com

Organizational Information

ACO Participants
Loudoun Medical Group PC

ACO Governing Body:

Key ACO Clinical and Administrative Leadership:

Mary Beth TamasyACO Executive
Anthony CrowleyMedical Director
Clara NussbaumCompliance Officer
Clara NussbaumQuality Assurance/Improvement Officer

Associated Committees and Committee Leadership:

Quality Assurance and Improvement Committee – Anthony Crowley, MD, Chair
Finance Committee –  Robert Hetzel, MD, Chair
Communications Committee – Linda Coleman, MD, Chair

Types of ACO participants, or combinations of participants, that formed the ACO:

  • ACO professionals in a group practice arrangement

Shared Savings and Losses

Amount of Shared Savings/Losses

  • Second Agreement Period
    • Performance Year 2017, $1,272,644
  • First Agreement Period
    • Performance Year 2016, $0
    • Performance Year 2015, $0
    • Performance Year 2014, $0

Shared Savings Distribution

    • Second Agreement Period
      • Performance Year 2017
        • Proportion invested in infrastructure: 30%
        • Proportion invested in redesigned care processes/resources: 30%
        • Proportion of distribution to ACO participants: 40%
    • First Agreement Period
      • Performance Year 2016
        • Proportion invested in infrastructure: N/A
        • Proportion invested in redesigned care processes/resources: N/A
        • Proportion of distribution to ACO participants: N/A
      • Performance Year 2015
        • Proportion invested in infrastructure: N/A
        • Proportion invested in redesigned care processes/resources: N/A
        • Proportion of distribution to ACO participants: N/A
      • Performance Year 2014
        • Proportion invested in infrastructure: N/A
        • Proportion invested in redesigned care processes/resources: N/A
        • Proportion of distribution to ACO participants: N/A

Quality Performance Results

2017 Quality Performance Results:

You may need to scroll horizontally to view all of the data.

ACO#Measure NameRateACO Mean
ACO-1CAHPS: Getting Timely Care, Appointments, and Information87.0780.6
ACO-2CAHPS: How Well Your Providers Communicate94.5593.13
ACO-3CAHPS: Patients’ Rating of Provider93.3892.31
ACO-4CAHPS: Access to Specialists84.8583.32
ACO-5CAHPS: Health Promotion and Education59.4962.3
ACO-6CAHPS: Shared Decision Making79.0375.85
ACO-7CAHPS: Health Status/Functional Status75.1373.05
ACO-34CAHPS: Stewardship of Patient Resources27.4225.68
ACO-8Risk Standardized, All Condition Readmission14.8115.01
ACO-35Skilled Nursing Facility 30-day All-Cause Readmission measure (SNFRM)17.0818.46
ACO-37All-Cause Unplanned Admissions for Patients with Heart Failure76.6479.16
ACO-38All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions54.2461.74
ACO-43Ambulatory Sensitive Condition Acute Composite (AHRQ* Prevention Quality Indicator (PQI #91))1.781.93
ACO-11Use of Certified EHR Technology10098.48
ACO-12Medication Reconciliation10075.32
ACO-13Falls: Screening for Future Fall Risk64.6974.38
ACO-44Imaging Studies for Low Back Pain94.1267.32
ACO-14Preventive Care and Screening: Influenza Immunization68.8172.52
ACO-15Pneumonia Vaccination Status for Older Adults77.2472.92
ACO-16Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up75.4470.69
ACO-17Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention99.3590.48
ACO-18Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan27.1561.98
ACO-19Colorectal Cancer Screening64.464.58
ACO-20Breast Cancer Screening57.0370.05
ACO-42Statin Therapy for the Prevention and Treatment of Cardiovascular Disease80.0779.89
ACO-27Diabetes Mellitus: Hemoglobin A1c Poor Control17.1516.74
ACO-41Diabetes: Eye Exam39.0550.37
ACO-28Hypertension (HTN): Controlling High Blood Pressure65.1271.47
ACO-30Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic91.2886.86

Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low samples and the ACO-36 All-Cause Unplanned Admissions for Patients with Diabetes quality measure is not included in public reporting due to a non-material technical error.

 

Note: In the Quality Performance Results file(s) above, search for “Loudoun Medical Group ACO LLC” to view the quality performance results. This ACO can also be found by using the ACO ID A36039 in the public use files on data.cms.gov.

Payment Rule Waivers

  • No, our ACO does not use the SNF 3-Day Rule Waiver.
Print Friendly, PDF & Email